Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Zvi Steinberg who wrote (517)	4/3/1998 11:43:00 PM
From: Zvi Steinberg	Read Replies (1) \| Respond to of 1491

From Yahoo (Someone who knows): "Lotemax, Alrex, and LotemaxT pars98 Apr 3 1998 9:53PM EST Lotemax will be introduced at a national surgery convention in San Diego on April 20th. The formal launch though will not commence until sometime in May and both Lotemax and Alrex will be launched at the same time. Product is already in the hands of some pharmacists and drug wholesalers. The formal launch won't be until May because 1. You must get the salesforce trained and updated on the drug. 2. Must insure that there is sufficient product ready for distribution so that upon launch, and B&L will be putting all there resources behing this launch, there will be no interuption in the sales channel. Also, Lotemax T looks to be very promising as its main competitor, Tobradex, which is Tobramyacin and dexi-something, has better than 50% market share and thus far, Lotemax T has a better safety profile and effectiveness vs. Tobradex. Also, though B&L won't officially comment on this yet, they believe the market for Alrex is much greater than currently being forcasted. "